financetom
Business
financetom
/
Business
/
Nike pins hopes on Olympics to win back market share
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nike pins hopes on Olympics to win back market share
Apr 11, 2024 4:08 AM

PARIS, April 11 (Reuters) - Nike ( NKE ) unveiled Olympic kits for the teams it sponsors on Thursday alongside athletes including Kenyan marathon star Eliud Kipchoge and British sprinter Dina Asher-Smith, betting that top athletes can help it win more everyday consumers.

After a long stretch of lacklustre sales, this summer's Olympic Games in Paris offer a fresh chance for Nike ( NKE ), to direct the world's attention to its performance products like the Alphafly 3 marathon shoe which retails at $285.

As well as outfitting U.S. athletes across all sports, Nike ( NKE ) will provide kit for the athletics teams of Canada, China, Kenya, Germany, and Uganda at the Olympics, basketball for China, France, Japan, and Spain, and athletes in breaking - a new breakdancing event at the Paris Games - for Korea.

The high-end shoes Nike ( NKE ) will spotlight at the Olympics serve a relatively limited audience but the broader goal for Nike ( NKE ) is to sell more entry-level and mid-range running shoes, and on Thursday it highlighted its Pegasus shoe range which retails at between $130 and $160.

Nike ( NKE ) spotlighted its "Air" cushioning technology, used in everything from marathon shoes to sneakers, and its knit materials that make shoes lighter.

"What we learn from our best athletes, 10% of the athletes we work with, there is a trickledown in innovation because we're focused on making sure our innovations work across body shapes and running speeds and styles," Matt Nurse, vice president of Nike's ( NKE ) sport innovation lab, told Reuters in an interview.

Brands like On Running, Hoka, and Lululemon are taking market share from Nike ( NKE ), while a trend away from chunky basketball sneakers and towards low-profile "terrace" shoes like the Adidas Samba is also hurting the sportswear giant.

"There's definitely more competition... it's good to take the pulse on what consumers are thinking and responding to - I just think competition always makes us better," said Nurse.

Nike ( NKE ) warned three weeks ago that its revenue in the first half of its 2025 financial year would shrink and said it would cut back on orders of established shoes such as the Air Force 1 as it tries to focus on new, innovative products.

While Nike ( NKE ), with annual revenue of $51.2 billion in the year to May 31, 2023, is much bigger than Adidas and Lululemon, analysts at HSBC expect its annual sales growth to lag those brands in 2024, 2025 and 2026.

"They haven't had a ton of exciting product innovation recently," said Tom Nikic, analyst at Wedbush in New York.

Seeing Olympians break records in Nike ( NKE ) gear could help push more shoppers to the brand. "It will remain to be seen whether Nike ( NKE ) has the strong product to capitalise on the attention it will get," said Nikic.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ARS Pharmaceuticals Reports Q4 Net Loss
ARS Pharmaceuticals Reports Q4 Net Loss
Mar 11, 2026
06:18 AM EDT, 03/09/2026 (MT Newswires) -- ARS Pharmaceuticals ( SPRY ) reported a Q4 net loss Monday of $0.42 per diluted share. Three analysts surveyed by FactSet expected a loss of $0.39. Revenue for the quarter ended Dec. 31 was $28.1 million. Analysts surveyed by FactSet expected revenue of $25.6 million. ...
ING Says Germany's Industrial Production Still Struggles to Gain Positive Momentum
ING Says Germany's Industrial Production Still Struggles to Gain Positive Momentum
Mar 11, 2026
06:19 AM EDT, 03/09/2026 (MT Newswires) -- German industrial production (IP) started the year on a weak footing, dropping by 0.5% month over month in January from an upwardly revised 1.0% month-over-month slip in December, said ING. The January drop was mainly driven by weaker production in the metal and pharmaceuticals industries, wrote the bank in a note. On the...
Agilent Technologies to Acquire Biocare Medical in $950 Million Deal
Agilent Technologies to Acquire Biocare Medical in $950 Million Deal
Mar 11, 2026
06:19 AM EDT, 03/09/2026 (MT Newswires) -- Agilent Technologies ( A ) on Monday agreed to acquire clinical pathology firm Biocare Medical from an investor group led by Excellere Partners and GHO Capital Partners in an all-cash deal worth about $950 million. Agilent ( A ) said the proposed acquisition is expected to strengthen its pathology portfolio and immunohistochemistry offerings....
Chevron in talks to buy stake in Brazil's Ipiranga, Brazil Journal reports
Chevron in talks to buy stake in Brazil's Ipiranga, Brazil Journal reports
Mar 11, 2026
SAO PAULO, March 9 (Reuters) - Oil producer Chevron ( CVX ) is in advanced talks with Brazilian conglomerate Ultrapar to purchase a 30% stake in fuel distributor Ipiranga, Brazil Journal reported on Monday, citing two sources familiar with the matter. Chevron ( CVX ) and Ultrapar did not immediately respond to requests for comment. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved